Lin Zhong

Dr. Lin Zhong


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MDMei Dong
Mei Dong
TYTing Yu
Ting Yu
ZZZhenzhen Zhang
Zhenzhen Zhang
JZJing Zhang
Jing Zhang
RWRujian Wang
Rujian Wang
LZLin Zhong
Lin Zhong
Immune checkpoint inhibitors (ICIs) are rapidly developing immunotherapy cancer drugs that have prolonged patient survival. However, ICIs-related cardiotoxicity has been recognized as a rare, but fatal, consequence. Although there has been extensive research based on different types of ICIs, these studies have not indicated whether cardiotoxicity is specific to a type of cancer. Therefore, we conducted a systematic review to analyze a variety of ICIs-related cardiotoxicity, focusing on different types of cancer. We found that the incidence of ICIs-related cardiac adverse events (CAEs) and common cardiotoxic manifestations vary with cancer type. This inspired us to explore the underlying mechanisms to formulate targeted clinical strategies for maintaining the cardiovascular health of cancer patients.

28 November 2022 in Current Problems in Cardiology
Verified
Journal Article
Closed access
MDMei Dong
Mei Dong
TYTing Yu
Ting Yu
GTGary Tse
Gary Tse
ZLZerun Lin
Zerun Lin
CLChen Lin
Chen Lin
LZLin Zhong
Lin Zhong

1 November 2024 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
BXBowen Xu
Bowen Xu
HLHongye Li
Hongye Li
HCHongping Chen
Hongping Chen
DTDa Teng
Da Teng
LGLei Gong
Lei Gong
JYJun Yang
Jun Yang
Objective: Atherosclerosis(AS) is a vascular disease characterized by the development of plaque in the arteries, and atrial fibrillation (AF) is a common heart arrhythmia. These two conditions share several risk factors in common, such as aging, diabetes, obesity, and hypertension. Ferroptosis is a new mode of non-apoptotic cell death that plays a key role in cardiomyocyte death and has been associated with a variety of cardiac diseases. This study aimed to investigate the ferroptosis biomarkers and underlying biological mechanisms associated with AF and AS. Materials and Methods: The gene expression dataset was obtained from GEO database, differentially expressed genes (DEGs) and ferroptosis expressed genes (FDGs) were obtained by data processing and screening, and then functional enrichment, network construction, transcription factor prediction, identification of biomarkers by LASSO and SVM - RFE algorithms, and also immune infiltration analyses and cellular experiments were performed. Results: In AF and AS, 1627 and 571 DEGs were identified respectively, and 128 were intersected, and 47 common FDGs were also identified. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis of DEGs revealed that they were associated with biological processes and pathways such as leukocyte immunity, and FDGs were also involved in specific functions and pathways. Fifteen key genes were identified, CSF1R and ITGAM expression differences were verified, and seven transcription factors were predicted to be differentially expressed. Characterized genes were screened to construct models with good diagnostic efficacy, and immune infiltration showed that NUPR1 was associated with altered immune environments, and WB indicated that NUPR1 was highly expressed in the disease model. Conclusion: Our study demonstrates that the ferroptosis gene NUPR1 plays a role in the pathogenesis of atrial fibrillation and atherosclerosis, and also provides valuable insights into their molecular mechanisms, which may contribute to the development of new targets and strategies for the treatment of these diseases.

1 April 2026 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
MRMengmeng Ren
Mengmeng Ren
YWYiming Wang
Yiming Wang
LZLin Zhong
Lin Zhong
CWChunxiao Wang
Chunxiao Wang
Background: Ischemic stroke is a leading cause of death and disability worldwide. Identifying patients with carotid atherosclerosis who are at high risk is clinically important. Acute coronary syndrome (ACS) is a manifestation of systemic atherosclerosis, in which inflammation plays a key role in plaque progression and destabilization. However, the relationship between blood cell-derived systemic inflammation indices and carotid plaque burden in patients with ACS remains unclear. Methods: This retrospective study included 7,178 patients with ACS. Carotid ultrasound was used to classify patients into carotid plaque and non-plaque groups. Systemic inflammation indices—including neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), neutrophil-to-monocyte-plus-lymphocyte ratio (NMLR), systemic inflammatory response index (SIRI), systemic immune-inflammatory index (SII), aggregate index of systemic inflammation (AISI), and platelet-to-lymphocyte ratio (PLR)—were calculated from routine blood tests. Multivariable logistic regression, restricted cubic spline models, and subgroup analyses were used to evaluate their associations with carotid plaques. Results: Patients with carotid plaques had significantly higher NLR, MLR, NMLR, SIRI, SII, AISI, and PLR. After full adjustment, MLR, SIRI, and AISI showed significant non-linear associations with carotid plaques, with inflection points of 0.26, 0.9, and 205, respectively. Compared with the lowest quartile, the highest quartile was associated with increased odds of carotid plaques for MLR (OR 1.453), SIRI (OR 1.409), and AISI (OR 1.379). Subgroup analyses showed that these associations were mainly observed in women and in non-diabetic patients. In patients with hypertension, MLR, SIRI, and AISI remained positively associated with carotid plaques. Conclusion: MLR, SIRI, and AISI are independently associated with carotid plaques in patients with ACS, particularly among women and non-diabetic individuals, and may serve as potential markers for ischemic stroke risk stratification in this population.